News - 2023
November 28, 2023 News
Oblique Therapeutics forms strategic collaboration with AAX Biotech
November 17, 2023 News
Oblique Therapeutics enters an agreement with a large US-based pharmaceutical company
October 10, 2023 News
Oblique Therapeutics presents at the Redeye Neurology Theme Event
Event at Redeye, January 16 at Redeye – Stockholm
March 8, 2023 News
Report launch: The Swedish Drug Discovery and Development Pipeline 2023
SwedenBIO launches the long-awaited 2023 edition of the large, recurring mapping of the Swedish pharmaceutical pipeline.
February 8, 2023 News
Oblique Therapeutics offentliggör utfall i genomförd företrädesemission
January 30, 2023 Event
Oblique Therapeutics is pleased to be participating in the Biotechgate Digital Partnering event
Virtual Business development and Licensing event - Feb 6 -10, 2023
January 4, 2023 News
Announcement of Oblique Therapeutics ‘s Rights Issue 2023
January 3, 2023 Event
Oblique Therapeutics is thrilled to be attending in person at the 41st Annual J.P. Morgan Healthcare Conference
January 9—12, 2023 | San Francisco, CA